Operating margin of the company fell 540 bps to 14.8%. Operating profit as a result decreased 31% to Rs 386.25 crore. Other income fell 24% to Rs 68.55 crore while interest cost decreased 4% to Rs 83.63 crore while depreciation rose 16% to Rs 192.43 crore. PBT was down 55% to Rs 178.73 crore.
Tax provisions rose 169% to Rs 57.07 crore. PAT as a result decreased 68% to Rs 121.66 crore. Considering share of profit or loss in associate and JV, Bottomline decreased 76% to Rs 70.46 crore.
Segment wise, Basic chemistry products revenue stood at Rs 1838.68 crore, down by 11% YoY and accounted for 70% of sales. PBIT from the same was down by 57% to Rs 151.56 crore and accounted for 63% of total PBIT with PBIT margin stood at 8.2% as compared to 17.3% for Sep19 quarter.
Sales from the Speciality products stood at Rs 766.17 crore up by 7% YoY and accounted for 29% of sales. PBIT from the same rose 2% to Rs 90.48 crore with PBIT margins at 11.8% compared to 12.4%.
Performance for half year ended Sep20
For H1FY21 Tata Chemicals reported 7% decrease in consolidated net sales to Rs 4957.51 crore compared to corresponding previous year period while net profit of the company was down 82% to Rs 83.74 crore compared to H1FY20.
Operating margin fell 510 bps to 15%. Operating profit as a result decreased 31% to Rs 746.01 crore.
Other income decreased 28% to Rs 127.21 crore while interest cost was up 11% to Rs 201.49 crore while depreciation was up 16% to Rs 382.34 crore. PBT was down 61% to Rs 289.38 crore.
Tax expenses were Rs 92.86 crore compared to Rs 132.76 crore. PAT fell 68% to Rs 196.52 crore. Considering share of profit or loss in associate and JV, Bottomline fell 82% to Rs 83.74 crore.
Commenting on the results, Mr. R. Mukundan, Managing Director & CEO, Tata Chemicals Ltd., said, With the country gradually reopening, we are witnessing the revival of the chemical sector and customer demand. Our plant operations and capacity utilisation have gained momentum and are getting back to the pre-COVID levels. While we are scaling up our operations and ensuring business continuity, the health and safety of our employees and customers will remain our priority. In the coming quarters, we are aiming to move up the value chain with our business strategy concentrating on four verticals - performance materials, nutritional sciences, agro sciences and energy sciences, while maintaining cash flow and cash balances.
The scrip is currently trading at Rs 320
Tata Chemicals: Consolidated Results
|Particulars||2009 (03)||1909 (03)||Var. (%)||2009 (06)||1909 (06)||Var. (%)||2003 (12)||1903 (12)||Var. (%)|
|PBT before notional Forex gain/loss||178.73||398.09||-55||289.38||743.08||-61||1251.90||1267.72||-1|
|PBT before EO||178.73||398.09||-55||289.38||743.08||-61||1251.90||1267.72||-1|
|PBT after EO||178.73||398.09||-55||289.38||743.08||-61||1251.90||1338.05||-6|
|Share in profit or loss in JV and Associate||10.42||2.19||9.71||-0.50||-3.85||99.21||-104|
|* Annualised on current equity of Rs 254.82 crore. Face Value: Rs 10 each |
# EPS not annualised due to seasonality of business
Var. (%) exceeding 999 has been truncated to 999
LP: Loss to Profit PL: Profit to Loss
EO: Extraordinary items
EPS is calculated after excluding EO and relevant tax
Figures in Rs crore
Source: Capitaline Corporate Database
Tata Chemicals: Consolidated Segment Results
|Particulars||2009 (03)||1909 (03)||% of total||Var. (%)||2009 (06)||1909 (06)||% of total||Var. (%)||2003 (12)||1903 (12)||% of total||Var. (%)|
|Basic Chemistry Products||1838.68||2056.31||70||-11||3510.99||4005.57||71||-12||8013.74||8309.05||77||-4|
|Less: Inter Segment Revenue||3.11||3.43||5.79||5.95||10.06||15.75|
|Net Sales/Income from Operation||2609.35||2771.27||100||13||4957.51||5355.30||100||13||10356.75||10336.72||100||13|
|Basic Chemistry Products||151.56||355.32||63||-57||263.23||673.52||59||-61||1355.51||1303.61||89||4|
Powered by Capital Market - Live News